Full Name
XXX Folefac Aminkeng
(not current staff)
Main Affiliation
 
 
Email
mdcfa@nus.edu.sg
 

Publications

Refined By:
Policy:  Closed

Results 1-20 of 32 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
11-Mar-2018An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclinesDionne, Francois; Aminkeng, Folefac ; Bhavsar, Amit P; Groeneweg, Gabriella; Smith, Anne ; Visscher, Henk; Rassekh, Shahrad Rod; Ross, Colin; Carleton, Bruce
2Aug-2023An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare ProvidersOni-Orisan, Akinyemi; Tuteja, Sony; Hoffecker, Glenda; Smith, D Max; Castrichini, Matteo; Crews, Kristine R; Murphy, William A; Nguyen, Nam HK; Huang, Yimei; Lteif, Christelle; Friede, Kevin A; Tantisira, Kelan; XXX Folefac Aminkeng ; Voora, Deepak; Cavallari, Larisa H; Whirl-Carrillo, Michelle; Duarte, Julio D; Luzum, Jasmine A
31-Nov-2017Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular CancerDrogemoller, Britt I; Monzon, Jose G; Bhavsar, Amit P; Borrie, Adrienne E; Brooks, Beth; Wright, Galen EB; Liu, Geoffrey; Renouf, Daniel J; Kollmannsberger, Christian K; Bedard, Philippe L; Aminkeng, Folefac ; Amstutz, Ursula; Hildebrand, Claudette A; Gunaretnam, Erandika P; Critchley, Carol; Chen, Zhuo; Brunham, Liam R; Hayden, Michael R; Ross, Colin JD; Gelmon, Karen A; Carleton, Bruce C
41-Dec-2010Association of IL-2RA/CD25 with type 1 diabetes in the Belgian populationAminkeng, Folefac ; Weets, Ilse; Van Autreve, Jan E; Koeleman, Bobby PC; Quartier, Erik; Van Schravendijk, Chris; Gorus, Frans K; Van der Auwera, Bart JR
51-Jun-2009Association of KIR2DL2 polymorphism rs2756923 with type 1 diabetes and preliminary evidence for lack of inhibition through HLA-C1 ligand bindingRamos-Lopez, E; Scholten, F; Aminkeng, F ; Wild, C; Kalhes, H; Seidl, C; Tonn, T; Van der Auwera, B; Badenhoop, K
61-Jan-2014Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: Relation to autoantibody status and comparison with Belgian patientsAsanghanwa, Milca; Gorus, Frans K; Weets, Ilse; Auwera, Bart V der; Aminkeng, Folefac ; Mbunwe, Eric; Goubert, Patrick; Verhaeghen, Katrijn; Sobngwi, Eugene; Wenzlau, Janet M; Hutton, John C; Pipeleers, Daniel G; Keymeulen, Bart; Mbanya, Jean-Claude N; van Schravendijk, Chris
71-Aug-2016Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic MarkersLee, JW; Pussegoda, K; Rassekh, SR; Monzon, JG; Liu, G; Hwang, S; Bhavsar, AP; Pritchard, S; Ross, CJ; Amstutz, U; Carleton, BC; Hayden, MR; MacLeod, S; Smith, A ; Brunham, L ; Aminkeng, F ; Shear, NH; Koren, G; Ito, S; Madadi, P; Rieder, MJ; Kim, R; Maher, M; Flockhart, D
81-Feb-2019CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelinesDrogemoller, Britt I; Wright, Galen EB; Shih, Joanne; Monzon, Jose G; Gelmon, Karen A; Ross, Colin JD; Amstutz, Ursula; Carleton, Bruce C; Chang, Wan C; Connolly, Mary B; Dionne, Francois; Groeneweg, Gabriella; Loucks, Catrina M; MacLeod, Stuart M; Pritchard, Sheila; Rassekh, Shahrad R; Sanatani, Shubhayan; Bhavsar, Amit P; Rieder, Michael J; Shear, Neil H; Ito, Shinya; Liu, Geoffrey; Khayat, Philip; Bernstein, Daniel; Lesko, Lawrence J; Aminkeng, Folefac 
91-Dec-2015DLL4 loss-of-function heterozygous mutations cause Adams-Oliver syndromeAminkeng, F 
101-Sep-2014EIF2AK4 genetic mutations cause a recessive form of rare and deadly lung disease, pulmonary veno-occlusive diseaseAminkeng, F 
111-Nov-2017Genetic Variation in SLC16A5 Confers Protection from Cisplatin-Induced Ototoxicity in Adult Testicular Cancer PatientsDrogemoller, Britt; Monzon, Jose; Bhavsar, Amit; Borrie, Adrienne; Brooks, Beth; Wright, Galen; Liu, Geoffrey; Fadhel, Ehab; Renouf, Daniel; Kollmannsberger, Christian; Bedard, Philippe; Aminkeng, Folefac ; Hildebrand, Claudette; Gunaretnam, Erandika; Critchley, Carol; Chen, Zhou; Brunham, Liam; Hayden, Michael; Ross, Colin; Gelmon, Karen; Carleton, Bruce
121-Nov-2017Genome-wide Scan Identifies Association Between an Interferon Regulatory Factor Variant and Interferon-beta Induced Liver Injury in Multiple Sclerosis PatientsKowalec, Kaarina; Wright, Galen EB; Drogemoller, Britt I; Aminkeng, Folefac ; Bhavsar, Amit P; Kingwell, Elaine; Yoshida, Eric M; Traboulsee, Anthony; Marrie, Ruth Ann; Kremenchutzky, Marcelo; Campbell, Trudy L; Duquette, Pierre; Chalasani, Naga; Wadelius, Mia; Hallberg, Par; Xia, Zongqi; De Jager, Philip; Ross, Colin; Tremlett, Helen; Carleton, Bruce
131-Jun-2014GFI1B mutation causes autosomal dominant gray platelet syndromeAminkeng, F 
141-Jan-2013HINT1 mutations define a novel disease entity - autosomal recessive axonal neuropathy with neuromyotoniaAminkeng, F 
151-Sep-2009IFIH1 gene polymorphisms in type 1 diabetes: Genetic association analysis and genotype-phenotype correlation in the Belgian populationAminkeng, Folefac ; Van Autreve, Jan E; Weets, Ilse; Quartier, Erik; Van Schravendijk, Chris; Gorus, Frans K; Van der Auwera, Bart J
161-Apr-2013KCNT1 mutations in ADNFLE and MMPSI: a new driver in the etiology and pathophysiology of early-onset epileptic syndromesAminkeng, F 
171-Jan-2006MICA is associated with type 1 diabetes in the Belgian population, independent of HLA-DQVan Autreve, Jan E; Koeleman, Bobby PC; Quartier, Erik; Aminkeng, Folefac ; Weets, Ilse; Gorus, Frans K; Van der Auwera, Bart JR
181-Nov-2017Multifactorial Prediction of Anthracycline-Induced Cardiotoxicity in Childhood Cancer: 10 Years of Active Surveillance and Pharmacogenomics Studies at the Canadian Pharmacogenomics Network for Drug SafetyAminkeng, Folefac ; Rassekh, Shahrad; Bhavsar, Amit; Luo, Hao; Wright, Galen; Drogemoller, Britt; Rieder, Michael; Hayden, Michael; Ross, Colin; Carleton, Bruce
191-Jan-2013Mutations in ATP1A3 cause alternating hemiplegia of childhoodAminkeng, F 
201-Aug-2006Neither an intronic CA repeat within the CD48 gene nor the HERV-K18 polymorphisms are associated with type 1 diabetesRamos-Lopez, E; Ghebru, S; Van Autreve, J; Aminkeng, F ; Herwig, J; Seifried, E; Seidl, C; Van der Auwera, B; Badenhoop, K